UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

PloS one, 2020-08, Vol.15 (8), p.e0238251-e0238251

2020

Volltextzugriff (PDF)

Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells

The Journal of pathology, 2024-08, Vol.263 (4-5), p.508-519

2024

Volltextzugriff (PDF)

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Gastroenterology (New York, N.Y. 1943), 2006-12, Vol.131 (6), p.1743-1751

2006

Volltextzugriff (PDF)

Vortex Ring Formation Following Shock Wave Diffraction in Low-Pressure Environments

Flow, turbulence and combustion, 2023-11, Vol.111 (4), p.1127-1138

2023

Volltextzugriff (PDF)

Urine DNA biomarkers for hepatocellular carcinoma screening

British journal of cancer, 2022-06, Vol.126 (10), p.1432-1438

2022

Volltextzugriff (PDF)

Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan

Liver international, 2021-11, Vol.41 (11), p.2671-2680

2021

Volltextzugriff (PDF)

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis

PloS one, 2019-11, Vol.14 (11), p.e0225482-e0225482

2019

Volltextzugriff (PDF)

Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2007-11, Vol.133 (5), p.1437-1444

2007

Volltextzugriff (PDF)

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Scientific reports, 2023-12, Vol.13 (1), p.21585-21585, Article 21585

2023

Volltextzugriff (PDF)

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program

Hepatology (Baltimore, Md.), 2015-06, Vol.61 (6), p.1870-1879

2015

Volltextzugriff (PDF)

Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations

Journal of biomedical science, 2018-06, Vol.25 (1), p.51-12, Article 51

2018

Volltextzugriff (PDF)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

PloS one, 2021-05, Vol.16 (5), p.e0251552-e0251552

2021

Volltextzugriff (PDF)

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.1929-1937

2021

Volltextzugriff (PDF)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

BMC infectious diseases, 2022-04, Vol.22 (1), p.351-9, Article 351

2022

Volltextzugriff (PDF)

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study

Liver international, 2016-10, Vol.36 (10), p.1433-1441

2016

Volltextzugriff (PDF)

A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-Refractory Chronic Hepatitis B Patients

Gastroenterology (New York, N.Y. 1943), 2005-10, Vol.129 (4), p.1198-1209

2005

Volltextzugriff (PDF)

Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatology international, 2021-12, Vol.15 (6), p.1421-1430

2021

Volltextzugriff (PDF)

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

Frontiers in immunology, 2017-05, Vol.8, p.621-621

2017

Volltextzugriff (PDF)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Viruses, 2022-08, Vol.14 (8), p.1812

2022

Volltextzugriff (PDF)

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Journal of hepatology, 2014-11, Vol.61 (5), p.984-993

2014

Volltextzugriff (PDF)

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatology international, 2024-06, Vol.18 (3), p.1066-1066

2024

Volltextzugriff (PDF)

Hepatocellular carcinoma‐associated single‐nucleotide variants and deletions identified by the use of genome‐wide high‐throughput analysis of hepatitis B virus

The Journal of pathology, 2017-10, Vol.243 (2), p.176-192

2017

Volltextzugriff (PDF)

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Hepatology international, 2021-12, Vol.15 (6), p.1456-1465

2021

Volltextzugriff (PDF)

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

PloS one, 2012-07, Vol.7 (7), p.e41931-e41931

2012

Volltextzugriff (PDF)

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Cellular microbiology, 2017-04, Vol.19 (4), p.np-n/a

2017

Volltextzugriff (PDF)

1 – 25 von 246

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(117)
Humans
(106)
Male
(73)
Female
(66)
Middle Aged
(61)
Adult
(54)
Gastroenterology & Hepatology
(51)
Aged
(43)
Hepatitis B Virus
(33)
Hepatocellular Carcinoma
(32)
Hepatitis B
(30)
Hepatitis
(28)
Physical Sciences
(27)
Antiviral Agents - Therapeutic Use
(26)
Hepatitis B Virus - Genetics
(26)
Hepatitis B, Chronic - Drug Therapy
(24)
Liver Cancer
(23)
Treatment Outcome
(22)
Medicine
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Vortex Ring Formation Following Shock Wave Diffraction in Low-Pressure Environments

Urine DNA biomarkers for hepatocellular carcinoma screening

Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis

Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program

Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study

A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-Refractory Chronic Hepatitis B Patients

Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatocellular carcinoma‐associated single‐nucleotide variants and deletions identified by the use of genome‐wide high‐throughput analysis of hepatitis B virus

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Aktive Filter

Suchergebnisse filtern